4th Liquid Biopsy for Precision Oncology East Coast

The 4th Liquid Biopsy for Precision Oncology East Coast Summit returns to Boston with a refreshed agenda, sharpened focus, and a renewed mission: to accelerate access to more sensitive, less invasive testing by addressing the most pressing challenges across the entire patient care continuum.

This year, we’ve updated the Summit’s name and expanded its scope. What began with a focus on early detection and recurrence monitoring has grown to reflect the full breadth of innovation across the liquid biopsy space – from MRD and treatment response to emerging applications in rare diseases, novel analytes, and beyond.

Bringing together leaders in Biomarker Development, Translational Research, Diagnostics, Clinical Development, Pathology, and beyond, this is the go-to East Coast forum for diving deep into the barriers slowing the adoption of liquid biopsy technologies.

Take home actionable insights to ensure you're maximizing the value of liquid biopsies in your therapeutic development strategies. Shape the future of precision oncology and be part of the conversations that will drive meaningful change for patients worldwide.

What’s more, this event is completely *FREE for drug developers and researchers for the entire 2 day conference, so claim your pass here (it only takes 2 minutes): https://ter.li/ghvt6p

If you need to explore the full event guide in more detail, feel free to download the brochure here: https://ter.li/rnyh6l

T&Cs are available on the website.